BioSpace News Archive

- Provides patients with access to latest-generation gold-standard heart stent through Japan’s health insurance system - XIENCE stents are among the most-widely used in the world, with unparalleled safety - New features help doctors more easily reach and treat difficult blockages in patients’ arteries

Illumina, Inc. announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack multiple cancers, today announced a strategic relationship with the Centre for Commercialisation of Cancer Immunotherapy (C3i), a catalyst for accelerating market access of breakthrough innovations to fight cancer

CEL-SCI Corporation announces that Geert Kersten, Chief Executive Officer, will present at upcoming conferences.

Verseon presented new efficacy results on its diabetic macular edema drug candidates at the Association for Research in Vision and Ophthalmology (ARVO) 2018 annual meeting in Honolulu this week.

Wounded Warrior Project® (WWP) Soldier Ride® recently returned to Washington, DC for its annual events at the White House and Annapolis.

Premise Health announced a new brand identity that reflects its evolution over the past year and vision for continued progress.

Echodyne has been named as a winner in the Detect and Avoid category of the XCELLENCE Awards by the Association for Unmanned Vehicles Systems International (AUVSI).

Behavioral science meets college-bound student success in Nudges, Norms, and New Solutions (http://nudge4.ideas42.org)

Coolibar is DETERMINED to change skin cancer and melanoma statistics.